Kindred biosciences, inc. (KIN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
Cash Flows from Operating Activities
Net loss

-22,761

-15,734

-15,293

-14,307

-16,055

-15,441

-13,037

-11,241

-9,971

-9,730

-7,890

-6,767

-6,492

-5,809

-5,683

-4,947

-6,060

-6,420

-7,095

-6,883

-6,732

-6,789

-6,072

-8,110

-6,168

-2,383

-1,210

-396

-224

-120

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

2,064

1,769

1,826

1,902

1,860

1,705

1,635

1,413

1,524

1,330

1,316

1,320

1,241

928

1,015

922

762

1,054

1,006

1,019

1,078

904

1,265

1,176

1,077

418

406

59

39

11

Depreciation and amortization expense

1,053

778

666

595

500

278

203

180

144

180

133

116

46

40

40

37

38

38

36

38

34

29

16

9

4

-

1

0

0

-

Loss/(gain) on disposal of property and equipment

0

-78

-12

-121

-1

-46

0

12

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on marketable securities

109

94

187

151

81

39

65

46

29

12

-12

-74

-88

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount of long-term loan

85

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finished goods write off related to Dechra asset purchase

3,494

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of (discount) premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

75

67

55

77

100

76

20

32

38

49

0

0

-

-

-

-

-

Depreciation and amortization expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Accounts receivable

-679

122

-136

662

-628

661

242

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

100

-5

-135

-167

955

1,049

2,521

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

1,398

966

-339

-62

260

197

-49

146

573

-117

-696

426

-98

395

-12

37

150

263

6

-148

114

-211

167

-52

425

-213

327

33

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts payable

1,558

147

782

2,484

-1,575

337

2,450

-1,283

-1,227

940

-175

-211

726

-851

362

-338

117

165

-816

754

-73

-324

-967

40

982

564

90

33

-4

6

Due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

-24

2

21

5

Accrued liabilities and accrued compensation

-1,677

360

646

-3,327

-2,717

2,164

-815

2,543

-1,090

1,376

1,176

388

-1,572

1,508

492

223

-1,268

-203

967

-81

-628

797

1

723

-263

648

393

126

17

36

Net Cash Provided by (Used in) Operating Activities, Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-209

-151

-

Net cash used in operating activities

-17,112

-13,695

-10,877

-13,116

-18,654

-12,878

-12,343

-8,592

-11,222

-5,784

-4,732

-5,497

-5,865

-4,517

-3,695

-4,085

-6,484

-5,529

-5,832

-4,993

-6,403

-5,134

-5,897

-6,110

-4,793

-

-

-

-

-62

Cash Flows from Investing Activities
Purchases of investments

16,720

35,941

39,664

29,134

20,281

6,647

4,164

9,010

5,279

23,222

21,912

8,620

16,356

10,565

14,281

13,528

33,673

21,109

45,204

10,754

25,128

-

-

-

-

-

-

-

-

-

Sales of investments

-

-

-

-

-

0

0

0

800

2,001

0

1,296

1,600

0

0

0

0

0

0

0

3,000

-

-

-

-

-

-

-

-

-

Maturities of investments

33,769

26,950

35,978

9,100

10,600

10,700

7,099

10,901

25,875

19,200

13,919

17,836

17,510

8,500

15,250

24,123

30,440

42,361

41,000

25,000

21,000

-

-

-

-

-

-

-

-

-

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,017

82,117

24,008

-

0

0

0

0

Sale of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

0

Maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,000

3,000

0

-

-

-

-

0

Purchases of property and equipment

1,418

1,147

625

4,000

2,656

5,437

6,124

1,949

409

1,172

3,846

570

332

114

6

168

664

407

247

44

31

229

101

91

19

1

13

1

0

0

Proceeds from sale of property and equipment

0

2

0

0

3

70

0

178

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

15,631

-10,136

-1,312

-24,034

-12,334

-1,314

-3,189

120

20,987

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

9,942

2,422

-

963

10,427

-3,897

-

-4,451

14,202

-1,159

-

4,882

-79,208

-24,027

-

-13

-1

0

-

Cash Flows from Financing Activities
Exercises of stock options

124

-

184

532

652

-

84

228

165

-

146

126

76

-

0

90

0

-

0

195

11

-

-

-

-

-

-

-

-

-

Payment of restricted stock awards and units tax liability on net settlement

669

0

0

0

493

0

0

0

247

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from note payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net proceeds from initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net proceeds from sale of common stock

0

0

0

0

43,125

0

2

49,178

0

0

23,198

12,416

16,546

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from note payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

Net cash (used in) provided by financing activities

-545

653

19,373

532

43,284

510

86

49,406

-82

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

Net change in cash and cash equivalents

-2,026

-23,178

7,184

-36,618

12,296

-13,682

-15,446

40,934

9,683

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

2

0

0

0

Payment of initial public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

12,542

16,622

-

0

90

0

-

0

195

11

-

1

58,143

4

-

8,564

2,535

0

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

6,773

16,987

13,179

-6,624

-2,732

6,432

-10,381

15,453

-10,283

9,404

-7,551

4,645

-1,014

-27,175

-28,816

54,337

7,880

2,325

-151

938

Cash paid for income taxes during the period

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Supplemental disclosure of non-cash investing and financing activities:
Conversion of note payable into Series AA convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

Offering costs in connection with Series AA convertible preferred stock recorded in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

Conversion of Series AA, Series A-1 and Series A-1A preferred stock into shares of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchases of property and equipment included in accounts payable and accrued liabilities

1,224

-191

909

-1,021

1,600

3,817

941

1,110

337

101

115

22

28

574

-2

0

98

-

-

-

0

-

-

-

-

-

-

-

-

-

Proceeds due from sale of common stock

-

-

-

-

-

-

-

-

-

-

-

-

2,090

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-